FindMyKOL
Clinical trialNCT00614445CompletedPhase 3Interventional

The Efficacy Of Diclectin® For Nausea And Vomiting Of Pregnancy

SponsorDuchesnay Inc.Enrollment280Nausea and Vomiting of Pregnancy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether Diclectin® (doxylamine succinate USP 10 mg and pyridoxine HCl 10 mg) is more effective at controlling the nausea and vomiting of pregnancy than a placebo.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • Washington Hospital Center Physicians

    Washington D.C., District of Columbia, United States

  • National Naval Medical Center

    Bethesda, Maryland, United States

  • Magee-Womens Hospital of University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

  • Utmb Pasadena Clinic

    Pasadena, Texas, United States

  • Utmb Regional Maternal & Child Health Program--Pearland Clinic

    Pearland, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboDoxylamine
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2008
Primary completion
31 Jul 2009
Completion
31 Dec 2009
Last update posted
23 Nov 2021
Registered enrollment
280
Registry id
NCT00614445
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.